关于「Weight Loss」的内容列表
Novo Nordisk announced on November 17 that Novo Yinying, the world's first and currently the only weekly preparation of glucagon-like peptide-1 receptor agonist (GLP-1) for long-term weight management, has been officially launched in China. Novo Yinying (smeglutide injection for long-term weight management) can achieve an average weight loss of about 17%, and its weight loss effect can last for at least 2 years. Up to now, smeglutide has accumulated more than 22 million years of experience in pa...
On August 10, the U.S. stock market closed, the three major stock indexes collectively closed up, the Dow index closed up 0.13%, the S & P 500 index closed up 0.47%, and the Nasdaq index closed up 0.51%. The weight loss drug sector led the gains, Eli Lilly (LLY. N) rose 5.5%, Novo Nordisk (NVO. N) rose more than 4%. Apple (AAPL. O) rose 1.37%.
All three major U.S. stock indexes rallied, with weight loss drug concept stocks gaining ground. Eli Lilly (LLY. N) rose more than 5 percent and Novo Nordisk (NVO. N) rose 3.9 percent.
